Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Liver Dis. 2010 Aug;14(3):477-93. doi: 10.1016/j.cld.2010.05.006.

Management of end-stage liver disease in chronic hepatitis B.

Author information

1
Department of Gastroenterology & Hepatology, Singapore General Hospital, Republic of Singapore. mhyhui@gmail.com

Abstract

The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.

PMID:
20638026
DOI:
10.1016/j.cld.2010.05.006
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center